{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:03:57Z","timestamp":1791540237548,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.cgh.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T02:30:33Z","timestamp":1146796233000},"page":"621-630","source":"Crossref","is-referenced-by-count":734,"title":["Serious Infections and Mortality in Association With Therapies for Crohn\u2019s Disease: TREAT Registry"],"prefix":"10.1016","volume":"4","author":[{"given":"Gary R.","family":"Lichtenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Feagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Salzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donny M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Sandborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2006.03.002_bib1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2004.02.070","article-title":"Optimizing anti-TNF treatment in inflammatory bowel disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199603283341307","article-title":"Drug therapy","volume":"334","author":"Hanauer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.002_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn\u2019s disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn\u2019s disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2006.03.002_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn\u2019s disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib8","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.002_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complication in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cgh.2006.03.002_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2002.05596.x","article-title":"Corticosteroids in Crohn\u2019s disease","volume":"97","author":"Yang","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.002_bib12","first-page":"423","article-title":"A review of immune modifier therapy for inflammatory bowel disease","volume":"91","author":"Sandborn","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.002_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0889-8529(18)30091-4","article-title":"Glucocorticoids and infection","volume":"23","author":"Aucott","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.cgh.2006.03.002_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0891-5520(05)70154-9","article-title":"Infections associated with steroid use","volume":"15","author":"Klein","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cgh.2006.03.002_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn\u2019s disease","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1572-0241.2001.03612.x","article-title":"Infliximab for Crohn\u2019s disease in clinical practice at the Mayo Clinic","volume":"96","author":"Ricart","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.002_bib17","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1111\/j.1572-0241.2000.03363.x","article-title":"Infliximab in Crohn\u2019s disease","volume":"95","author":"Cohen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.002_bib18","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/j.1572-0241.2000.03366.x","article-title":"Clinical experience with infliximab therapy in 100 patients with Crohn\u2019s disease","volume":"95","author":"Farrell","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.002_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","article-title":"Management of Crohn\u2019s disease in adults","volume":"96","author":"Hanauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.03.002_bib20","series-title":"Applied logistic regression","author":"Hosmer","year":"1998"},{"key":"10.1016\/j.cgh.2006.03.002_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.2003.018515","article-title":"Infliximab in inflammatory bowel disease","volume":"53","author":"Ljung","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.03.002_bib22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/gast.2002.33632","article-title":"Mortality and causes of death in Crohn\u2019s disease","volume":"122","author":"Jess","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0016-5085(98)70421-4","article-title":"Crohn\u2019s disease in Olmstead County, Minnesota, 1940-1993","volume":"114","author":"Loftus","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib24","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/0016-5085(85)90006-X","article-title":"Long-term follow-up of patients with Crohn\u2019s disease. Relationship between clinical pattern and prognosis","volume":"88","author":"Farmer","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/0016-5085(92)90029-X","article-title":"Survival and causes of death in patients with inflammatory-bowel disease","volume":"103","author":"Ekbom","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","article-title":"6-mercaptopurine in the management of inflammatory bowel disease","volume":"111","author":"Present","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2006.03.002_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","article-title":"Corticosteroids and immunomodulators","volume":"125","author":"Aberra","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.03.002_bib28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1440-1746.2001.02468.x","article-title":"Chronic narcotic use in inflammatory bowel disease patients","volume":"16","author":"Edwards","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.03.002_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004836-198806000-00010","article-title":"Narcotic dependence in inflammatory bowel disease","volume":"10","author":"Kaplan","year":"1988","journal-title":"J Clin Gastroenterol"}],"updated-by":[{"DOI":"10.1016\/j.cgh.2006.05.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000}}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235650600228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235650600228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T12:25:17Z","timestamp":1555590317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235650600228X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S154235650600228X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2006.03.002","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}